Publications by authors named "Shoudong Guo"

Claim this Profile
R
Retraction Note: Exogenous supplement of N-acetylneuraminic acid improves macrophage reverse cholesterol transport in Apolipoprotein E-deficient mice.
Pengbo Hou, Shumei Hu, Jin Wang, Zixun Yang, Jiayu Yin, Shoudong Guo

Lipids Health Dis· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The combination of Fucus vesiculosus-derived fucoidan and simvastatin attenuates atherosclerosis induced by a high-fat diet plus balloon catheter injury in New Zealand rabbits.
Shan-Rui Shi, Jun-Wei Xin, Hong-Hai Ji, Chao-Nan Ma, Feng-Yu Liu, Shou-Dong Guo

Int J Biol Macromol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms of action of Fucus vesiculosus-derived fucoidan on improving dyslipidemia in New Zealand rabbits fed a high-fat diet.
Xue Wang, Shan-Rui Shi, Min-Min Sun, Xue-Ying Zhang, Xu-Hang Zhang, Shou-Dong Guo

Int J Biol Macromol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preparation and bioactivities of low-molecular weight fucoidans and fuco-oligosaccharides: A review.
Hai-Di Liu, Dong-Yue Ma, Shan-Rui Shi, Shi-Lin Song, Wen-Lan Li, Shou-Dong Guo

Carbohydr Polym· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted Drug Nanodelivery and Immunotherapy for Combating Tumor Resistance.
Yun Liu, Xinyu Sun, Chen Wei, Shoudong Guo, Chunxiao Song

Comb Chem High Throughput Screen· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms underlying the effects of the conditional knockdown of hepatic PCSK9 in attenuating lipopolysaccharide-induced acute liver inflammation.
Miao Miao, Xue-Ying Zhang, Hai-Xin Yu, Shan-Rui Shi, Chao-Nan Ma, Shou-Dong Guo

Int J Biol Macromol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conditional knockdown of hepatic PCSK9 ameliorates high-fat diet-induced liver inflammation in mice.
Xue-Ying Zhang, Qing-Qing Lu, Yan-Jie Li, Shan-Rui Shi, Chao-Nan Ma, Shou-Dong Guo

Front Pharmacol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting PDGF/PDGFR Signaling Pathway by microRNA, lncRNA, and circRNA for Therapy of Vascular Diseases: A Narrow Review.
Chao-Nan Ma, Shan-Rui Shi, Xue-Ying Zhang, Guo-Song Xin, Xiang Zou, Shou-Dong Guo

Biomolecules· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: A comparative study of the hypolipidemic effects and mechanisms of action of - and -derived fucoidans in apolipoprotein E-deficient mice.
Tian Liu, Xue Wang, Yan-Ming Wang, Feng-Rong Sui, Xue-Ying Zhang, Shou-Dong Guo

Food Funct· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design of Nanodrug Delivery Systems for Tumor Bone Metastasis.
Xiaoqing Zhai, Shan Peng, Chunyuan Zhai, Shuai Wang, Meina Xie, Shoudong Guo

Curr Pharm Des· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparative study of the hypolipidemic effects and mechanisms of action of - and -derived fucoidans in apolipoprotein E-deficient mice.
Tian Liu, Xue Wang, Yan-Ming Wang, Feng-Rong Sui, Xue-Ying Zhang, Shou-Dong Guo

Food Funct· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exserolide J ameliorates lipid accumulation by regulating liver X receptor alpha and peroxisome proliferator-activated receptor alpha proteins.
Yan Zhang, Xue Wang, Tian Liu, Zi-Yi Zhang, Wen-Gang Song, Shou-Dong Guo

Heliyon· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural products in atherosclerosis therapy by targeting PPARs: a review focusing on lipid metabolism and inflammation.
Yan Zhang, Xue-Ying Zhang, Shan-Rui Shi, Chao-Nan Ma, Yun-Peng Lin, Shou-Dong Guo

Front Cardiovasc Med· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Aresch-Derived Fucoidan Ameliorates Hyperlipidemia by Upregulating LXRs and Suppressing SREBPs.
Yan Zhang, Tian Liu, Ze-Jie Qu, Xue Wang, Wen-Gang Song, Shou-Dong Guo

Cardiovasc Ther· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting PPARs for therapy of atherosclerosis: A review.
Miao Miao, Xue Wang, Tian Liu, Yan-Jie Li, Wen-Qian Yu, Shou-Dong Guo

Int J Biol Macromol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CM3-SII polysaccharide obtained from Cordyceps militaris ameliorates hyperlipidemia in heterozygous LDLR-deficient hamsters by modulating gut microbiota and NPC1L1 and PPARα levels.
Wen-Qian Yu, Xiao-Lei Wang, Hong-Hai Ji, Miao Miao, Bai-Hui Zhang, Shou-Dong Guo

Int J Biol Macromol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting macrophages in atherosclerosis using nanocarriers loaded with liver X receptor agonists: A narrow review.
Tong-Mei Yang, Miao Miao, Wen-Qian Yu, Xue Wang, Fang-Jie Xia, Shou-Dong Guo

Front Mol Biosci· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fenofibrate enhances lipid deposition via modulating PPARγ, SREBP-1c, and gut microbiota in mice fed a high-fat diet.
Ying Zhang, Xiu-Bin Jia, Yun-Chao Liu, Wen-Qian Yu, Yan-Hong Si, Shou-Dong Guo

Front Nutr· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sea cucumber-derived compounds for treatment of dyslipidemia: A review.
Ping Lin, Nuo Shen, Fan Yin, Shou-Dong Guo

Front Pharmacol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-density lipoprotein particles in atherosclerosis.
Ya-Nan Qiao, Yan-Li Zou, Shou-Dong Guo

Front Physiol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Triglyceride and Triglyceride-Rich Lipoproteins in Atherosclerosis.
Bai-Hui Zhang, Fan Yin, Ya-Nan Qiao, Shou-Dong Guo

Front Mol Biosci· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural Elucidation and Activities of -Derived Polysaccharides: A Review.
Miao Miao, Wen-Qian Yu, Yuan Li, Yan-Long Sun, Shou-Dong Guo

Front Nutr· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Biochemical Parameters between Mouse Model and Human after Paraquat Poisoning.
Jielun Yu, Lichun Zhang, Xiaoshuang Li, Kaixuan Lv, Shiyu Sun, Guifang Guo, Shoudong Guo

Biomed Res Int· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the PDGF/PDGFR signaling pathway for cancer therapy: A review.
Xiang Zou, Xi-Yu Tang, Zhong-Yuan Qu, Zhi-Wei Sun, Chen-Feng Ji, Shou-Dong Guo

Int J Biol Macromol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The polysaccharide-peptide complex from mushroom ameliorates atherosclerosis by modulating the lncRNA-miRNA-mRNA axis.
Yuan Li, Miao Miao, Fan Yin, Nuo Shen, Wen-Qian Yu, Shou-Dong Guo

Food Funct· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis